Andrew Labelle
Impact in
-
- Antibiotic Use and Resistance
- Infectious Diseases top 5%
- Antifungal resistance and susceptibility
Papers in
-
- Pneumonia and Respiratory Infections 3
- Sepsis Diagnosis and Treatment 2
- Autoimmune and Inflammatory Disorders 1
-
- Antifungal resistance and susceptibility 3
- Co-authors
- Marin H. Kollef (8 shared papers)Scott T. Micek (6 shared papers)Heather Arnold (3 shared papers)Richard M. Reichley (3 shared papers)Nareg H. Roubinian (1 shared paper)Marya D. Zilberberg (2 shared papers)Smita Kothari (2 shared papers)Andrew F. Shorr (2 shared papers)
- Journals
- Critical Care Medicine (3 papers)Clinics in Chest Medicine (1 paper)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (1 paper)BMC Infectious Diseases (1 paper)CHEST Journal (1 paper)
- Partner nations
- United StatesIndia
In The Last Decade
Andrew Labelle
9 papers receiving 595 citations
Peers
Comparison fields: 5 of 62
- Applied Microbiology and Biotechnology 47
- Infectious Diseases 265
- Critical Care and Intensive Care Medicine 50
- Epidemiology 306
- Clinical Biochemistry 53
Countries citing papers authored by Andrew Labelle
This map shows the geographic impact of Andrew Labelle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Labelle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Labelle more than expected).
Fields of papers citing papers by Andrew Labelle
This network shows the impact of papers produced by Andrew Labelle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Labelle. The network helps show where Andrew Labelle may publish in the future.
Co-authors
The 15 scholars most cited alongside Andrew Labelle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 145 | |
| 2 | 2010 | 134 | |
| 3 | 2010 | 104 | |
| 4 | 2010 | 83 | |
| 5 | 2009 | 74 | |
| 6 | 2012 | 61 | |
| 7 | 2011 | 8 | |
| 8 | 2014 | 2 | |
| 9 | 2012 | 1 |
About Andrew Labelle
Andrew Labelle is a scholar working on Epidemiology, Infectious Diseases, Critical Care and Intensive Care Medicine, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 9 papers that have together received 612 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (3 papers), Pneumonia and Respiratory Infections (3 papers), Sepsis Diagnosis and Treatment (2 papers), Nosocomial Infections in ICU (2 papers), Autoimmune and Inflammatory Disorders (1 paper), Antibiotic Use and Resistance (1 paper), Vasculitis and related conditions (1 paper) and Antibiotic Resistance in Bacteria (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (47 citations), Infectious Diseases (265 citations), Critical Care and Intensive Care Medicine (50 citations), Epidemiology (306 citations) and Clinical Biochemistry (53 citations). Andrew Labelle has collaborated with scholars based in United States and India. Frequent co-authors include Marin H. Kollef, Scott T. Micek, Heather Arnold, Richard M. Reichley, Nareg H. Roubinian, Marya D. Zilberberg, Smita Kothari, Andrew F. Shorr, Eli N. Deal and Kevin Heard. Their work appears in journals such as Critical Care Medicine, Clinics in Chest Medicine, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, BMC Infectious Diseases and CHEST Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.